Directory
>
Leukemia Department-Hagop Kantarjian
Leukemia Department-Hagop Kantarjian
Associate Vice President for Global Academic Programs
Houston, Texas, United States
Leukemia Department-Hagop Kantarjian
Summary
Dr. Hagop Kantarjian is a distinguished leader in the field of oncology, currently serving as the Department Chair of the Department of Leukemia at the MD Anderson Cancer Center. With an extensive career spanning over three decades at MD Anderson, he has held multiple significant roles, including Associate Vice President for Global Academic Programs and Research Chair of the Department of Leukemia. Dr. Kantarjian is renowned for his contributions to leukemia research and treatment, making him a pivotal figure in advancing cancer medicine. He earned his medical degrees from the American University of Beirut, where he specialized in Internal Medicine. His commitment to patient care and academic excellence has established him as a respected authority in his field. Beyond his clinical responsibilities, Dr. Kantarjian is actively involved in global academic programs, fostering collaboration and innovation in cancer treatment. His work has not only impacted patient outcomes but also shaped the future of oncology education and research.
Leukemia Department-Hagop Kantarjian
Work Experience
Associate Vice President for Global Academic Programs at
The University of Texas M D Anderson Cancer Center
September 2010 - Present
Kelcie Margaret Kana - Research Chair, Department of Leukemia at
The University of Texas M D Anderson Cancer Center
January 1998 - Present
Department Chair, Department of Leukemia, Division of Cancer Medicine at
The University of Texas M D Anderson Cancer Center
September 1995 - Present
Professor, Department of Leukemia, Division of Cancer Medicine, at
The University of Texas M D Anderson Cancer Center
September 1993 - Present
Leukemia Department-Hagop Kantarjian
Education
American University of Beirut, Internal Medicine
January 1981
American University of Beirut, Md
January 1979
American University of Beirut, Bs
January 1975
American University of Beirut, Baccalaureateii
January 1972
Frequently Asked Questions about Leukemia Department-Hagop Kantarjian
What is Leukemia Department-Hagop Kantarjian email address?
Leukemia Department-Hagop Kantarjian's primary email address is ********@mdanderson.org. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Leukemia Department-Hagop Kantarjian graduated from?
Leukemia Department-Hagop Kantarjian holds a degree in Internal Medicine from American University of Beirut.
How can I directly contact Leukemia Department-Hagop Kantarjian?
To contact Leukemia Department-Hagop Kantarjian directly, you can use the email address ********@mdanderson.org. Complete contact information is available upon registration with Muraena.
Is Leukemia Department-Hagop Kantarjian an immigrant?
Yes, Leukemia Department-Hagop Kantarjian is an immigrant and currently based in United States
Who is Leukemia Department-Hagop Kantarjian?
Dr. Hagop Kantarjian is a distinguished leader in the field of oncology, currently serving as the Department Chair of the Department of Leukemia at the MD Anderson Cancer Center. With an extensive career spanning over three decades at MD Anderson, he has held multiple significant roles, including Associate Vice President for Global Academic Programs and Research Chair of the Department of Leukemia. Dr. Kantarjian is renowned for his contributions to leukemia research and treatment, making him a pivotal figure in advancing cancer medicine. He earned his medical degrees from the American University of Beirut, where he specialized in Internal Medicine. His commitment to patient care and academic excellence has established him as a respected authority in his field. Beyond his clinical responsibilities, Dr. Kantarjian is actively involved in global academic programs, fostering collaboration and innovation in cancer treatment. His work has not only impacted patient outcomes but also shaped the future of oncology education and research.
Leukemia`s contact details
********@mdanderson.org